The present application describes modulators of MCP-1 of formula (I):
##STR00001## or pharmaceutically acceptable salt forms thereof, useful
for the prevention of rheumatoid arthritis, multiple sclerosis,
atherosclerosis, asthma, restinosis, organ transplantation, and cancer.